Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Efficacy of Utidelone Plus Capecitabine Versus Capecitabine for Heavily Pretreated, Anthracycline- and Taxane-Refractory Metastatic Breast Cancer: Final Analysis of Overall Survival in a Phase 3 Randomised Controlled TrialAnn. Oncol 2020 Nov 11;[EPub Ahead of Print], B Xu, T Sun, Q Zhang, P Zhang, Z Yuan, Z Jiang, X Wang, S Cui, Y Teng, XC Hu, J Yang, H Pan, Z Tong, H Li, Q Yao, Y Wang, Y Yin, P Sun, H Zheng, J Cheng, J Lu, B Zhang, C Geng, J Liu, K Shen, S Yu, H Li, L Tang, R Qiu
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.